Subcutaneous formulation (refrigerated) for HER2-positive breast cancer treatment.
• Vial Contain: Pertuzumab, Trastuzumab & Hyaluronidase
• Used For Patients With Breast Cancer.
• Subcutaneous In Thigh Only (Not Intra Vascular)
• Side Effects: Cardiomyopathy, Embryo-Fetal Toxicity, Pulmonary Toxicity.